OA08325A - Antigens of plasmodium falciparum. - Google Patents

Antigens of plasmodium falciparum.

Info

Publication number
OA08325A
OA08325A OA58856A OA58856A OA08325A OA 08325 A OA08325 A OA 08325A OA 58856 A OA58856 A OA 58856A OA 58856 A OA58856 A OA 58856A OA 08325 A OA08325 A OA 08325A
Authority
OA
OAPI
Prior art keywords
antigens
plasmodium falciparum
falciparum
plasmodium
Prior art date
Application number
OA58856A
Other languages
English (en)
Inventor
David James Kemp
Robin Fredric Anders
Ross Leon Coppel
Graham Vallancey Brown
Robert Bryce Saint
Alan Frederick Cowman
Albert Edward Bianco
Graham Frank Mitchell
Robin Frederic Anders
Original Assignee
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall filed Critical Inst Medical W & E Hall
Publication of OA08325A publication Critical patent/OA08325A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA58856A 1984-09-11 1986-05-07 Antigens of plasmodium falciparum. OA08325A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG706784 1984-09-11
AUPG706684 1984-09-11

Publications (1)

Publication Number Publication Date
OA08325A true OA08325A (en) 1988-02-29

Family

ID=25642846

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58856A OA08325A (en) 1984-09-11 1986-05-07 Antigens of plasmodium falciparum.

Country Status (13)

Country Link
EP (1) EP0193586B1 (xx)
JP (1) JPH0698773A (xx)
AU (1) AU599305B2 (xx)
CA (1) CA1340213C (xx)
DE (1) DE3587503T2 (xx)
GB (1) GB2176191B (xx)
HK (1) HK132693A (xx)
IL (1) IL76338A (xx)
MY (1) MY102593A (xx)
OA (1) OA08325A (xx)
SG (2) SG65089G (xx)
WO (1) WO1986001802A1 (xx)
ZW (1) ZW14985A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
AU606042B2 (en) * 1985-12-24 1991-01-31 Saramane Pty Ltd Asexual blood stage antigens of plasmodium falciparum
WO1987003882A1 (en) * 1985-12-24 1987-07-02 The Walter And Eliza Hall Institute Of Medical Res Asexual blood stage antigens of plasmodium falciparum
EP0297110A4 (en) * 1986-03-14 1989-12-19 Saramane Pty Ltd POLYPEPTIDES WITH IMMUNE AGAINST MALARIA.
EP0261248B1 (en) * 1986-03-20 1991-05-29 Sawai Pharmaceutical Co., Ltd. $g(a), $g(a)-TREHALOSE TRIMYCOLATE AND MEDICINAL COMPOSITION
IT1213576B (it) * 1986-12-23 1989-12-20 Eniricerche Spa Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.
FR2672290B1 (fr) 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
US5532133A (en) * 1993-06-02 1996-07-02 New York University Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
DK79985A (da) * 1984-02-22 1985-08-23 Wellcome Found Kloning af dna for protozoelle antigener og dets anvendelse
EP0215059A4 (en) * 1985-02-20 1988-04-13 Sloan Kettering Inst Cancer CDNA FOR CODING PROTEINS BINDING WITH PLASMODIUM FALCIPARUM GLYCOPHORIN WEIGHING 130,000 DALTONS AND 155,000 DALTONS.

Also Published As

Publication number Publication date
HK132693A (en) 1993-12-10
EP0193586A1 (en) 1986-09-10
ZW14985A1 (en) 1986-01-29
AU4732685A (en) 1986-03-20
DE3587503T2 (de) 1993-11-25
IL76338A (en) 1994-08-26
GB2176191A (en) 1986-12-17
GB8610243D0 (en) 1986-05-29
DE3587503D1 (en) 1993-09-09
MY102593A (en) 1992-08-17
JPH0698773A (ja) 1994-04-12
EP0193586B1 (en) 1993-08-04
WO1986001802A1 (en) 1986-03-27
SG65089G (en) 1990-01-26
GB2176191B (en) 1989-06-01
CA1340213C (en) 1998-12-15
SG119293G (en) 1994-01-21
EP0193586A4 (en) 1988-03-22
AU599305B2 (en) 1990-07-19

Similar Documents

Publication Publication Date Title
GB8500182D0 (en) Forming capsules
GB8424104D0 (en) P falciparum
AU557570B2 (en) Antigen from parasite of plasmodium
GB2096893B (en) Antigens from parasites of the genus plasmodium
GB2099300B (en) Antigens from parasites of the genus plasmodium
OA08325A (en) Antigens of plasmodium falciparum.
EP0252098A4 (en) ANTIGENS IN THE ASEXUAL BLOOD PHASE OF -i (PLASMODIUM FALCIPARUM).
EP0217877A4 (en) VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
ZA858034B (en) Antigens
ZA856960B (en) Antigens of plasmodium falciparum
GB2200642B (en) Small molecular weight antigen of plasmodium falciparum
EP0344257A4 (en) TOXONEMIC ANTIGEN OF -i (PLASMODIUM FALCIPARUM).
AU7699887A (en) Merozoite surface antigen of plasmodium falciparum
GB8404493D0 (en) Malaria vaccines
ZA862732B (en) Highly repetitive antigens of plasmodium falciparum
GB2200641B (en) Merozoite surface antigen of plasmodium falciparum
ZA875266B (en) Merozoite surface antigen of plasmodium falciparum
GB8428643D0 (en) Production of malaria vaccines
GB8432337D0 (en) Production of malaria vaccines
EG16749A (en) Malaria associated antigen and preparing process thereof
GB2165536B (en) The preparation of piperonal
IE852633L (en) Preparation of guanine-related acyclonucleosides.
IE850797L (en) Preparation of 4-acetylimidazoles.
PL255297A1 (en) Method of obtaining 5,5,6,6,7,7,7-heptafluoro-4,4-bis/trifluoromethyl/-heptene-1
ZA875265B (en) Small molecular weight antigen of plasmodium falciparum